Active substance

Results for the substance rimegepant

3 results

About this active substance

Rimegepant is a medication used for the acute treatment of migraine, with or without aura, in adults. It acts as a CGRP (calcitonin gene-related peptide) receptor antagonist, reducing pain and other symptoms associated with migraine.

The medication is taken orally, as directed by a doctor, usually at the onset of migraine symptoms. It is important for patients not to exceed the maximum recommended dose within a 24-hour period.

Patients should be aware of potential side effects, such as nausea, fatigue, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, fatigue, and dry mouth. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.